Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119357-34-5

Post Buying Request

119357-34-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119357-34-5 Usage

Uses

The racemic metabolite of Dapoxetine (D185700). Selective serotonin reuptake inhibitor antidepressant.

Check Digit Verification of cas no

The CAS Registry Mumber 119357-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,3,5 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 119357-34:
(8*1)+(7*1)+(6*9)+(5*3)+(4*5)+(3*7)+(2*3)+(1*4)=135
135 % 10 = 5
So 119357-34-5 is a valid CAS Registry Number.

119357-34-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name rac N-Didemethyl Dapoxetine

1.2 Other means of identification

Product number -
Other names 3-(1-Naphthyloxy)-1-phenyl-1-propanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:119357-34-5 SDS

119357-34-5Relevant articles and documents

Development of novel triazole based dendrimer supported spiroborate chiral catalysts for the reduction of (: E)-O-benzyl oxime: An enantioselective synthesis of (S)-dapoxetine

Anandhan, Ramasamy,Reddy, Mandapati Bhargava,Sasikumar, Murugesan

, p. 15052 - 15056 (2019/10/08)

Novel dendrimer supported spiroborate catalysts 2 and 3 have been synthesized using a click reaction as a key step. The catalytic efficiency of the catalysts have been verified with reduction of (E)-O-benzyl oxime 13 as a model substrate. Catalyst 3 was found to be better than catalyst 2 as the chemical yield and enantiomeric excess were significantly high with the former catalyst. Thus, catalyst 3 has been successfully used in the efficient synthesis of (S)-dapoxetine 14 with 94% ee and 46% overall yield in three steps. These catalysts could be easily recovered from the reaction solution by the solvent precipitation technique and could be reused five times without significant loss of activity and enantioselectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119357-34-5